Jon,
Good point. There are obvious differences between Cmax, the maximum serum concentration after dose, the average serum concentration, and the serum concentration of maximum therapeutic effect. Tmax, the time interval at which Cmax occurs is another important pharmacokinetic parameter we need to know and understand in preventing CH with verapamil.
In my opinion, all of us need to understand the pharmacokinetics and pharmacodynamics of any pharmaceutical like verapamil or neutraceutical like vitamin D3 we take.
If you look at my original post on this topic, I was careful to say "serum concentration" and not serum concentration of maximum therapeutic effect. The two can be the same if the average serum concentration is higher than the threshold for a therapeutic effect.
The following two graphs illustrate what I'm talking about. The first graph illustrates plots of verapamil's serum concentration over time from dose for sublingual and oral administrations.
Multimedia File Viewing and Clickable Links are available for Registered Members only!! You need to

or

As you can see the shape of these two plots are very similar. You can also see that the sublingual verapamil plot reaches a higher Cmax at 55 ng/mL 1 hour after dose, where the oral verapamil reaches a lower Cmax at 45 ng/mL 1.5 hours after dose.
The second graph illustrates one measure of verapamil's therapeutic effect, measured in PR interval. Please note that this is not the therapeutic effect that prevents CH. It's just an example.
Multimedia File Viewing and Clickable Links are available for Registered Members only!! You need to

or

In electrocardiography, the PR interval is the period, measured in milliseconds, that extends from the beginning of the P wave (the onset of atrial depolarization) until the beginning of the QRS complex (the onset of ventricular depolarization); it is normally between 120 and 200ms in duration. See graphic below:
Multimedia File Viewing and Clickable Links are available for Registered Members only!! You need to

or

In this case, verapamil increases the PR interval which slows the heart's pulse rate and this lowers the blood pressure, one of verapamil's therapeutic effects.
The actual mechanism of action of verapamil in preventing CH remains unknown, but likely deals with its capacity as a calcium channel blocker which causes the smooth muscles lining arteries and capillaries to relax. This helps stop or slow the rapid vasodilation associated with the pain phase of CH.
As illustrated above, it takes it takes roughly an hour and a half for verapamil to reach peak plasma concentration after oral administration. It is metabolized in the liver to at least 12 inactive metabolites (though one metabolite, norverapamil, retains 20% of the vasodilating activity of the parent drug).
So, after this long-winded epistle, the simple answer to your question is there's a dose response relationship for verapamil in preventing CH. As there are considerable variations between CH'ers in terms of preventative response at any given dose of verapamil, it's always best to titrate up in dose to find the lowest effective dose of verapamil in preventing CH.
Your practice of taking verapamil in the evening as it results in the best CH preventative effect is sound... and supported by plots of serum Cmax and Tmax for verapamil illustrated in the first graphic.
Now for the rest of the story as Paul Harvey used to say... Verapamil, even at relatively low doses (120 mg/day), results in arrhythmia in roughly 20% of the CH'ers who take it to prevent CH. That makes having an EKG prior to starting verapamil to establish a baseline and periodic EKGs (3 month intervals) during the first year of use a very good idea...
Please understand... I'm not a doctor or a nutritionist... I'm just a cranky 71 year old fighter pilot with a bee in his bonnet trying to introduce CH'ers to an effective, lasting and healthy method of preventing their CH...
In order to do this with any credibility, I've gone back to school (make that home schooling) over the last five years, to learn how and why vitamin D3 is so effective in preventing CH. The pharmacokinetics and pharmacodynamics of vitamin D3 (and other pharmaceuticals used to prevent CH) were two of the courses...
I'll leave you with a parting thought...
In the history of modern medicine, medical scientists have yet to discover a medical condition caused by the lack of a pharmaceutical agent that wasn't already found naturally in the human body...
Take care and please keep us posted.
V/R, Batch